Seer (NASDAQ:SEER - Get Free Report) is scheduled to announce its earnings results after the market closes on Wednesday, November 6th. Analysts expect the company to announce earnings of ($0.29) per share for the quarter. Seer has set its FY 2024 guidance at EPS.Individual interested in participating in the company's earnings conference call can do so using this link.
Seer (NASDAQ:SEER - Get Free Report) last announced its earnings results on Thursday, August 8th. The company reported ($0.35) earnings per share for the quarter, beating the consensus estimate of ($0.36) by $0.01. Seer had a negative return on equity of 21.26% and a negative net margin of 559.21%. The company had revenue of $3.07 million for the quarter, compared to the consensus estimate of $3.33 million. During the same period last year, the business posted ($0.37) EPS. On average, analysts expect Seer to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Seer Trading Down 1.0 %
Shares of Seer stock traded down $0.02 during trading hours on Wednesday, hitting $1.96. 66,321 shares of the company were exchanged, compared to its average volume of 452,161. The business has a 50-day moving average of $1.80 and a 200-day moving average of $1.83. Seer has a 1 year low of $1.46 and a 1 year high of $2.30. The stock has a market capitalization of $120.40 million, a price-to-earnings ratio of -1.55 and a beta of 1.46.
Analyst Ratings Changes
Separately, Morgan Stanley reduced their target price on shares of Seer from $7.00 to $3.00 and set an "equal weight" rating for the company in a research note on Tuesday, August 13th.
Check Out Our Latest Report on Seer
Seer Company Profile
(
Get Free Report)
Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.
Featured Stories
Before you consider Seer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Seer wasn't on the list.
While Seer currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
